Home Bioverativ

Bioverativ

acquired
-
A Global Biotechnology Company

Basic Information

Dedicated to transforming the lives of patients with hemophilia and other rare blood disorders through the research, development, and commercialization of world-class innovative therapies.
Bioverativ
United States of America
101~500 people
January 01, 2016
media@bioverativ.com